Literature DB >> 3013831

Surgery of hepatoma with intracavitary cardiac extension.

H Goto, Y Kaneko, J Utoh, K Nishimura, Y Miyauchi, K Iwanaga.   

Abstract

A case of primary liver carcinoma with intracavitary cardiac extension is presented. A 36-year-old female was admitted to our surgical clinic with dyspnea and generalized edema. Echocardiography and superior vena cavography demonstrated a large filling defect in the right atrium. After a diagnosis of acute cardiac failure due to an intracardiac tumor, the patient was operated upon immediately. A right atriotomy exposed a large yellow mass within the right atrium, which was not adherent to the atrial wall. The mass was in continuity with similar material in the inferior vena cava and right hepatic vein. With a suspicion of hepatic malignancy, the atrial tumor was removed, and debulking of the mass in the inferior vena cava and right hepatic vein was performed. A postoperative histological examination of the tumor showed hepatocellular carcinoma. Her postoperative course was uneventful, and she was discharged from the hospital. Intracardiac extension of hepatoma is rarely encountered. In this clinical setting, long-term survival cannot be anticipated from any surgery, but palliative clearing of the atrium and inferior vena cava may be of value in preventing cardiac arrest causing sudden death.

Entities:  

Mesh:

Year:  1986        PMID: 3013831     DOI: 10.1007/bf02060248

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  7 in total

1.  Intracavitary cardiac extension of hepatoma.

Authors:  D A Ehrich; J J Widmann; R L Berger; W H Abelmann
Journal:  Ann Thorac Surg       Date:  1975-02       Impact factor: 4.330

2.  Surgery of tumors of the subdiaphragmatic inferior vena cava. Report of two cases and review of the literature.

Authors:  J D Hill; R Hetzer
Journal:  J Thorac Cardiovasc Surg       Date:  1978-07       Impact factor: 5.209

3.  Acute obstruction of tricuspid valve by Wilms' tumor.

Authors:  J R Utley; K Mobin-Uddin; R H Segnitz; R P Belin; J F Utley
Journal:  J Thorac Cardiovasc Surg       Date:  1973-10       Impact factor: 5.209

4.  Vena cava resection for renal cell carcinoma.

Authors:  D L Mccullough; R F Gittes
Journal:  J Urol       Date:  1974-08       Impact factor: 7.450

5.  Extension of renal cell carcinoma into the vena cava: the rationale for aggressive surgical management.

Authors:  D G Skinner; R F Pfister; R Colvin
Journal:  J Urol       Date:  1972-05       Impact factor: 7.450

6.  Primary liver tumor presenting as right atral tumor: a case report.

Authors:  C R Lam; D Webb; E Green
Journal:  Surgery       Date:  1966-05       Impact factor: 3.982

7.  Wilms' tumour propagated through the inferior vena cava into the right heart cavities.

Authors:  G Anselmi; J A Suárez; I Machado; F Moleiro; P Blanco
Journal:  Br Heart J       Date:  1970-07
  7 in total
  4 in total

1.  Magnetic resonance imaging of the heart in a case of hepatocellular carcinoma extending into the right atrium.

Authors:  P Dendale; B op de Beeck; F de Ridder; F Claessens; M Osteaux; P Block
Journal:  Int J Card Imaging       Date:  1994-09

2.  Echocardiography of a right atrial mass in hepatocellular carcinoma.

Authors:  Y Yoshitomi; S Kojima; T Sugi; Y Matsumoto; M Yano; Y Ozeki; M Kuramochi
Journal:  Heart Vessels       Date:  1998       Impact factor: 2.037

3.  Risk factors for patients with stage IVB hepatocellular carcinoma and extension into the heart: prognostic and therapeutic implications.

Authors:  Chung Hwan Jun; Da Woon Sim; Sang Ho Kim; Hyoung Ju Hong; Min Woo Chung; Sung Bum Cho; Chang Hwan Park; Young Eun Joo; Hyun Soo Kim; Sung Kyu Choi; Jong Sun Rew
Journal:  Yonsei Med J       Date:  2014-03       Impact factor: 2.759

4.  Hepatocellular Carcinoma With Tumor Thrombus Occupying the Right Atrium and Portal Vein: A Case Report and Literature Review.

Authors:  Xin Luo; Binhao Zhang; Shuilin Dong; Bixiang Zhang; Xiaoping Chen
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.